HYDERABAD — In a sweeping joint operation, teams from the Anti-Corruption Bureau (ACB), the Food Safety Department, and the Drug Control Administration conducted surprise inspections at the Nizam's Institute of Medical Sciences (NIMS) on Tuesday, targeting deep-seated allegations of institutional graft and regulatory non-compliance.
The high-stakes intervention follows a surge of complaints regarding administrative malpractice, procurement irregularities, and compromised patient safety standards at the premier state-run medical facility. For months, whistleblowers and internal factions have flagged concerns over preferential vendor awarding and substandard medical inventory management within the hospital ecosystem.
According to reports by The Hindu, regulatory authorities initiated the sudden sweep to independently verify mounting evidence of financial misconduct and procedural shortcuts. Investigators meticulously combed through vital procurement ledgers, pharmacy storage units, and administrative records while questioning key personnel on duty.
As the multi-agency probe gathers momentum, authorities are expected to release a comprehensive findings report that could trigger high-level disciplinary actions and sweeping institutional overhauls. The outcome of this investigation is likely to set a strict regulatory precedent for major healthcare facilities across the country facing similar allegations of administrative decay.